{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:31:18Z","timestamp":1778509878070,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Isr J Health Policy Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Following other countries, Israel passed the Vaccine Injury Compensation Law in 1989, which provides for compensation to vaccine recipients who had suffered injuries without proving negligence. In 2021, after deliberations between the ministries of health and of finance Covid-19 vaccines (administered from the beginning of the campaign on December 20, 2020 and up to December 21, 2022) were included within the compensation law. The current study aims to examine the objectives of Israel\u2019s Vaccine Injury Compensation Law, at the time of its enactment, and to explore barriers to their fulfillment. These issues are especially relevant in light of the discussions held on the option for liability exemption which excludes the possibility of redress from the Covid-19 vaccine manufacturers in case of injury attributed to the vaccine, and considering the heavy burden of proof required in standard tort law.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study employed a qualitative methodology which made use of both content analysis of relevant documents and in-depth interviews.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In passing the Vaccine Injury Compensation Law, legislators sought to assist vaccine recipients who had suffered injuries by both lowering their burden of proof as well as establishing a short and efficient procedure for deliberating their claims. Furthermore, legislators believed that the assurance of compensation to vaccine recipients who had suffered injuries would help to encourage a high rate of vaccination compliance. An examination of the law\u2019s implementation over time revealed that the aforementioned goals were not attained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Implementation of the law since its enactment missed the opportunity to fulfill its original purposes to promote public health fundamental principles of fairness and solidarity. In addition, the adversarial proceedings as well as some of the law\u2019s provisions have the potential to undermine public trust in the State\u2019s willingness to grant compensation for injuries that are attributed to vaccines and thereby subvert the law\u2019s pivotal objective of promoting trust and vaccine compliance. We suggest that allowing circumstantial evidence as to an association between vaccine and an injury, transitioning to administrative deliberation, making available to the public details of cases where compensation was awarded, as well as other possible emendations would help it better reflect the values of fairness and solidarity that underlying the law's purpose. These would also promote the level of trust in healthcare authorities which is essential to preserving high vaccine coverage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13584-021-00490-w","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T09:03:01Z","timestamp":1631523781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vaccine injury compensation: the Israeli case"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8870-4760","authenticated-orcid":false,"given":"Shelly","family":"Kamin-Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadav","family":"Davidovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"10254","key":"490_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(20)31873-0","volume":"396","author":"AL Phelan","year":"2020","unstructured":"Phelan AL, Eccleston-Turner M, Rourke M, Maleche A, Wang C. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access. Lancet. 2020;396(10254):800\u20132.","journal-title":"Lancet"},{"key":"490_CR2","unstructured":"Arlozorov M. Who is responsible for Corona vaccine damages? Not the manufacturer. TheMarker. https:\/\/www.themarker.com\/coronavirus\/.premium-1.9310434 (2010). Accessed 20 Mar 2021."},{"key":"490_CR3","unstructured":"Vaccine Injury Compensation Law. Book of Laws 1989;17:1292."},{"key":"490_CR4","first-page":"89","volume":"15","author":"Y Englard","year":"2020","unstructured":"Englard Y. Constitutional cause for compensation of vaccine recipients who had suffered injuries. Mishpatim Hebrew Univ Law Rev. 2020;15:89\u2013104.","journal-title":"Mishpatim Hebrew Univ Law Rev"},{"key":"490_CR5","unstructured":"Civil appeal 470\/87 Juhar Altouri v. State of Israel\u2014Ministry of Health (1993). PD 47(4) 146 (Isr.)."},{"key":"490_CR6","unstructured":"Civil case 614\/81 Lifshitz v. State of Israel. Unpublished; quoted at: Vaccine Injury Compensation Bill debate. Proceedings; 11th Knesset 1987. https:\/\/knesset.gov.il\/tql\/knesset_new\/knesset11\/HTML_27_03_2012_05-59-19-PM\/19880105@19880105047@047.html."},{"key":"490_CR7","unstructured":"Civil appeal 2015\/20 Anonymous v. State of Israel\u2014Ministry of Health (2020) (Nevo)."},{"key":"490_CR8","unstructured":"Vaccine Injury Compensation Regulations. Regulations file 1992;5491:274 ((Isr.)."},{"key":"490_CR9","first-page":"14","volume":"38","author":"B Kahana","year":"2008","unstructured":"Kahana B. Vaccine Injury Compensation Law\u2014a law that is not implemented. Refua Ve-Mishpat. 2008;38:14\u201327.","journal-title":"Refua Ve-Mishpat"},{"key":"490_CR10","unstructured":"Tzabar Ben Yehoshua N. Qualitative research in teaching and learning. Masada. 1990."},{"key":"490_CR11","volume-title":"Words that try to touch: qualitative research theory and application","author":"A Shkedi","year":"2004","unstructured":"Shkedi A. Words that try to touch: qualitative research theory and application. Ramot: Tel Aviv University Press; 2004."},{"issue":"9","key":"490_CR12","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388. https:\/\/doi.org\/10.1177\/1049732305276687.","journal-title":"Qual Health Res"},{"key":"490_CR13","unstructured":"Keelan J, Wilson K. Designing a no-fault vaccine-injury compensation program for Canada: lessons learned from an international analysis of programs. Munk school briefings, University of Toronto; 2011."},{"key":"490_CR14","first-page":"201","volume":"12","author":"NJ Kutlesa","year":"2004","unstructured":"Kutlesa NJ. Creating a sustainable immunization system in Canada\u2014the case for a vaccine-related injury compensation scheme. Health Law J. 2004;12:201\u201342.","journal-title":"Health Law J"},{"key":"490_CR15","unstructured":"Vaccine Injury Compensation Bill 1988;235:1891."},{"key":"490_CR16","unstructured":"Vaccine Injury Compensation Bill debate. Proceedings; 11th Knesset 1987. https:\/\/knesset.gov.il\/tql\/knesset_new\/knesset11\/HTML_27_03_2012_05-59-19-PM\/19880105@19880105047@047.html."},{"key":"490_CR17","unstructured":"Labor and Welfare Committee meeting: Vaccine Injury Compensation Law. Proceedings; 11th Knesset 1988. https:\/\/oknesset.org\/meetings\/2\/0\/2047214.html."},{"key":"490_CR18","unstructured":"Vaccine Injury Compensation Bill debate. Proceedings; 12th Knesset 1989. https:\/\/fs.knesset.gov.il\/12\/Plenum\/12_ptm_531419.PDF."},{"issue":"1","key":"490_CR19","first-page":"275","volume":"15","author":"DT Fisch","year":"2010","unstructured":"Fisch DT. Determining the conditions for proving scientific matters in law: philosophy and not science. Hamishpat. 2010;15(1):275\u2013311.","journal-title":"Hamishpat"},{"issue":"1","key":"490_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1467-8519.2007.00590.x","volume":"22","author":"MM Mello","year":"2008","unstructured":"Mello MM. Rationalizing vaccine injury compensation. Bioethics. 2008;22(1):32\u201342. https:\/\/doi.org\/10.1111\/j.1467-8519.2007.00590.x.","journal-title":"Bioethics"},{"issue":"1","key":"490_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jetl-2021-0005","volume":"12","author":"K Watts","year":"2021","unstructured":"Watts K, Popa T. Injecting fairness into Covid-19 vaccine injury compensation: no-fault solutions. J Eur Tort Law. 2021;12(1):1\u201339.","journal-title":"J Eur Tort Law"},{"issue":"5","key":"490_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233334","volume":"15","author":"RG Mungwira","year":"2020","unstructured":"Mungwira RG, Guillard C, Salda\u00f1a A, Okabe N, Petousis-Harris H, Agbenu E, Rodewald L, Zuber P. Global landscape analysis of no-fault compensation programmes for vaccine injuries: a review and survey of implementing countries. PLoS ONE. 2020;15(5): e0233334. https:\/\/doi.org\/10.1371\/journal.pone.0233334.","journal-title":"PLoS ONE"},{"key":"490_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13584-016-0119-y","volume":"5","author":"H Boas","year":"2016","unstructured":"Boas H, Rosenthal A, Davidovitch N. Between individualism and social solidarity in vaccination policy: the case of the 2013 OPV campaign in Israel. Israel J Health Policy Res. 2016;5:64. https:\/\/doi.org\/10.1186\/s13584-016-0119-y.","journal-title":"Israel J Health Policy Res"},{"issue":"2","key":"490_CR24","first-page":"549","volume":"26","author":"M Albertstein","year":"2010","unstructured":"Albertstein M, Davidovich N. Therapeutic jurisprudence and public health: an Israeli study. Mehkarei Mishpat. 2010;26(2):549\u201388.","journal-title":"Mehkarei Mishpat"},{"issue":"3","key":"490_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10654-011-9577-2","volume":"26","author":"I Gilles","year":"2011","unstructured":"Gilles I, Bangerter A, Cl\u00e9mence A, Green EG, Krings F, Staerkl\u00e9 C, Wagner-Egger P. Trust in medical organizations predicts pandemic (H1N1) 2009 vaccination behavior and perceived efficacy of protection measures in the Swiss public. Eur J Epidemiol. 2011;26(3):203\u201310. https:\/\/doi.org\/10.1007\/s10654-011-9577-2.","journal-title":"Eur J Epidemiol"},{"key":"490_CR26","unstructured":"USC Chapter 6A, subchapter XIX, Part 2: National Vaccine Injury Compensation Program. https:\/\/uscode.house.gov\/view.xhtml?path=\/prelim@title42\/chapter6A\/subchapter19\/part2&edition=prelim (The National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C.A. \u00a7\u00a7 300aa-10 et seq.)."},{"key":"490_CR27","unstructured":"Menashe D. A critical comment to the inquiry report on the Kishon stream. Hearat Din 2004; 1. https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=3068692."},{"key":"490_CR28","unstructured":"Civil appeal 1639\/01Kibbutz Maayan Zvi v. Yitzhak Krischov. 2004. (Nevo)."},{"key":"490_CR29","unstructured":"Civil appeal 6120q13 Michael Azmon v. Haifa Chemicals Ltd. 2015. (Nevo)."},{"key":"490_CR30","unstructured":"N.W. v. Sanofi Pasteur MSD SNC. Case C-621\/15. http:\/\/curia.europa.eu\/juris\/document\/document.jsf?text&docid=192054&pageIndex=0&doclang=EN&mode=req&dir&occ=first&p%20art=1&cid=848112 (2017)."},{"key":"490_CR31","unstructured":"Perry R. A misrepresented reform: the story of the Road Accidents Victims' Compensation Act. University of Haifa. https:\/\/law.haifa.ac.il\/images\/A_Misrepresented_Reform_The_Story_of_the_Road_Accidents_Victims_Compensation_Act.pdf (2004)."},{"key":"490_CR32","first-page":"415","volume":"67","author":"MS Holland","year":"2018","unstructured":"Holland MS. Liability for vaccine injury: the United States, the European Union, and the developing world. Emory Law J. 2018;67:415\u201362.","journal-title":"Emory Law J"},{"key":"490_CR33","unstructured":"Health resources and services administration. Countermeasures Injury Compensation Program (CICP). https:\/\/www.hrsa.gov\/cicp\/about. Accessed 20 Mar 2021."},{"key":"490_CR34","first-page":"1631","volume":"163","author":"NF Engstrom","year":"2015","unstructured":"Engstrom NF. A dose of reality for specialized courts: lessons from the VICP. Univ Pa Law Rev. 2015;163:1631\u2013717.","journal-title":"Univ Pa Law Rev"},{"key":"490_CR35","first-page":"303","volume":"42","author":"WS Waldenberg","year":"2007","unstructured":"Waldenberg WS, Wallace SE. When science is silent: examining compensation of vaccine-related injuries when scientific evidence of causation in inconclusive. Wake Forest Law Rev. 2007;42:303\u201331.","journal-title":"Wake Forest Law Rev"}],"container-title":["Israel Journal of Health Policy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-021-00490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13584-021-00490-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-021-00490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T09:06:26Z","timestamp":1631523986000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijhpr.biomedcentral.com\/articles\/10.1186\/s13584-021-00490-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1186\/s13584-021-00490-w","relation":{},"ISSN":["2045-4015"],"issn-type":[{"value":"2045-4015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee for Research in the Ben-Gurion University of the Negev, Beersheba, Israel, as meeting the requirements of ethical research. The study informants agreed to their participation in the study and to the recording and transcription of their interviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}